BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2357000)

  • 1. The immunopathology of gross cystic disease fluid proteins.
    Mazoujian G; Haagensen DE
    Ann N Y Acad Sci; 1990; 586():188-97. PubMed ID: 2357000
    [No Abstract]   [Full Text] [Related]  

  • 2. Review of GCDFP-15. An apocrine marker protein.
    Haagensen DE; Dilley WG; Mazoujian G; Wells SA
    Ann N Y Acad Sci; 1990; 586():161-73. PubMed ID: 2192632
    [No Abstract]   [Full Text] [Related]  

  • 3. Epidermal growth factor and prolactin in human breast cyst fluid. Possible correlations with GCDFP-15.
    Collette J; Van Cauwenberge JR; Dejardin L; Carlisi A; Jaspar JM; Franchimont P
    Ann N Y Acad Sci; 1990; 586():146-57. PubMed ID: 2356996
    [No Abstract]   [Full Text] [Related]  

  • 4. Breast cyst fluid proteins and breast cancer.
    Zangerle PF; Spyratos F; Le Doussal V; Noel G; Hacene K; Hendrick JC; Gest J; Franchimont P
    Ann N Y Acad Sci; 1986; 464():331-49. PubMed ID: 3089095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphologic and functional aspects of apocrine metaplasia in dysplastic and neoplastic breast tissue.
    Bussolati G; Cattani MG; Gugliotta P; Patriarca E; Eusebi V
    Ann N Y Acad Sci; 1986; 464():262-74. PubMed ID: 3524352
    [No Abstract]   [Full Text] [Related]  

  • 6. Adenomyoepithelioma of the breast with a distinctive type of apocrine adenosis.
    Eusebi V; Casadei GP; Bussolati G; Azzopardi JG
    Histopathology; 1987 Mar; 11(3):305-15. PubMed ID: 2828217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of tumor and trophoblastic marker concentration in breast cyst fluid.
    Luciani S; Carenza L; Pala A; Amelio G; Cascialli G; Pirozzi F; Pozzi M; Pozzi V
    Ann N Y Acad Sci; 1990; 586():218-29. PubMed ID: 2357003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemistry of a component protein of the breast cystic disease fluid with mol. wt 15,000.
    Le Doussal V; Zangerle PF; Collette J; Spyratos F; Hacene K; Briere M; Franchimont P; Gest J
    Eur J Cancer Clin Oncol; 1985 Jun; 21(6):715-25. PubMed ID: 3894034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gross cystic disease fluid protein-15 as a marker for breast cancer: immunohistochemical analysis of 690 human neoplasms and comparison with alpha-lactalbumin.
    Wick MR; Lillemoe TJ; Copland GT; Swanson PE; Manivel JC; Kiang DT
    Hum Pathol; 1989 Mar; 20(3):281-7. PubMed ID: 2542151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of GCDFP-15 in breast carcinomas. Relationship to pathologic and clinical factors.
    Mazoujian G; Bodian C; Haagensen DE; Haagensen CD
    Cancer; 1989 Jun; 63(11):2156-61. PubMed ID: 2655863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical study of cyst fluid in human breast cystic disease: a review.
    Enriori CL; Novelli JE; Cremona Mdel C; Hirsig RJ; Enriori PJ
    Breast Cancer Res Treat; 1992; 24(1):1-9. PubMed ID: 1463866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Symposium: New markers in hormone-dependent cancers].
    Ann Endocrinol (Paris); 1985; 46(4-5):325-41. PubMed ID: 3837633
    [No Abstract]   [Full Text] [Related]  

  • 13. Mammary origin of metastases. Immunohistochemical determination.
    Chaubert P; Hurlimann J
    Arch Pathol Lab Med; 1992 Nov; 116(11):1181-8. PubMed ID: 1444749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody sources.
    Mazoujian G
    Am J Surg Pathol; 1991 Dec; 15(12):1207-8. PubMed ID: 1660678
    [No Abstract]   [Full Text] [Related]  

  • 15. Estrogen and progesterone receptors in breast cancer.
    Couch P
    Am J Dermatopathol; 1997 Oct; 19(5):553-5. PubMed ID: 9335253
    [No Abstract]   [Full Text] [Related]  

  • 16. Breast gross cystic disease protein 15 in human breast cancer in culture.
    Miller WR; Shivas AA; Franchimont P; Haagensen DE
    Eur J Cancer Clin Oncol; 1988 Feb; 24(2):223-8. PubMed ID: 3356211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assay of GCDFP-15 by ELISA: an available method for in vitro studies of functional differentiation in human breast cancer.
    Revillion-Carette F; Hornez L; Vandewalle B; Lefebvre J
    Tumori; 1988 Dec; 74(6):669-74. PubMed ID: 3232212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor markers for breast carcinoma.
    Haagensen DE
    Clin Lab Med; 1982 Sep; 2(3):543-65. PubMed ID: 6754225
    [No Abstract]   [Full Text] [Related]  

  • 19. Analysis of amniotic fluid, maternal plasma, and cord blood for a human breast gross cystic disease fluid protein.
    Haagensen DE; Gall SA; Brazy JE; Giannola J; Wells SA
    Am J Obstet Gynecol; 1980 Sep; 138(1):25-32. PubMed ID: 7416203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presence of alpha-lactalbumin, epidermal growth factor, epithelial membrane antigen, and gross cystic disease fluid protein (15,000 daltons) in breast cyst fluid.
    Collette J; Hendrick JC; Jaspar JM; Franchimont P
    Cancer Res; 1986 Jul; 46(7):3728-33. PubMed ID: 3486713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.